Development and Evaluation of a Monolithic Floating Dosage Form for Furosemide

Grahnen, 1984, Clin. Pharmacol, 27, 595

Ritschel, 1991, Meth. Find. Exp. Clin. Pharmacol, 13, 629

Brodie, 1957, J. Pharm. Pharmacol, 9, 345, 10.1111/j.2042-7158.1957.tb12289.x

Beerman, 1975, J. Clin. Pharmacol, 9, 57, 10.1007/BF00613429

Sheth, 1984, Drug Dev. Ind. Pharm, 10, 313, 10.3109/03639048409064653

Ritschel, 1986, Meth. Find. Exp. Clin. Pharmacol, 8, 633

Ritschel, 1990, Meth. Find. Exp. Clin. Pharmacol, 12, 47

Data, 1978, J. Pharmacol. Exp. Ther, 206, 431

Yakatan, 1979, Res. Commun. Chem. Path. Pharmacol, 24, 465

Lin, 1979, J. Chromatogr, 163, 315, 10.1016/S0378-4347(00)81421-8

Hanson, 1991, 87

Peppas, 1985, Pharm. Acta Helv, 60, 110

Ford, 1991, Int. J. Pharm, 71, 95, 10.1016/0378-5173(91)90071-U

Rubinstein, 1988, 125

Oth, 1992, Pharm. Res, 9, 298, 10.1023/A:1015870314340

Hammarlund-Udenaes, 1989, J. Pharmacokin. Biopharm, 17, 1, 10.1007/BF01059086

Stuber, 1982, Arzneim-Forsch./Drug Res, 32, 693

Veng-Pedersen, 1980, J. Pharmacokin. Biopharm, 8, 463, 10.1007/BF01059546

Proost, 1985, J. Pharm. Sci, 74, 1135, 10.1002/jps.2600741031